Deployment o the Multidisciplinary Prospective Cohort Imminent

NARecruitingINTERVENTIONAL
Enrollment

2,200

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

July 31, 2031

Study Completion Date

July 31, 2031

Conditions
Chronic Inflammatory DiseaseAngioedemaSevere AsthmaLupusAtopic DermatitisPsoriatic ArthritisMultiple SclerosisSystemic SclerosisBehçet Disease
Interventions
GENETIC

Biobanking with genetic analysis

Patients included in the IMMINeNT cohort will be collected 7 blood samples for the research project at each revaluation visit. For patients who accepted, genetic analysis (DNA analysis) will be done on a part of those samples.

OTHER

SF-12 questionnaire

Patients included in the IMMINeNT cohort will be asked to complete SF-12 quality of life questionnaire.

Trial Locations (1)

59037

RECRUITING

Hop Claude Huriez Chu Lille, Lille

All Listed Sponsors
collaborator

FHU IMMINeNT

UNKNOWN

collaborator

FHU PRECISE: Projet Fédératif Hospitalo-Universitaire PREcision health in Complex Immune-mediated inflammatory diseaSEs

UNKNOWN

collaborator

Fond de dotation de la Société Française de Dermatologie (SFD)

UNKNOWN

lead

University Hospital, Lille

OTHER